GSK3B and hepatocellular carcinoma: Li et al. discovered that SNHG5 contributed to the proliferation and migration of hepatocellular carcinoma (HCC) cells through regulating GSK3β and the Wnt/β-catenin signalling pathway by competitively binding miR-26a-5p [33].